115 related articles for article (PubMed ID: 11749723)
1. Hepatitis B virus MHBs antigen is selectively sensitive to glucosidase-mediated processing in the endoplasmic reticulum.
Lu X; Lu Y; Geschwindt R; Dwek RA; Block TM
DNA Cell Biol; 2001 Oct; 20(10):647-56. PubMed ID: 11749723
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus large and middle glycoproteins are degraded by a proteasome pathway in glucosidase-inhibited cells but not in cells with functional glucosidase enzyme.
Simsek E; Mehta A; Zhou T; Dwek RA; Block T
J Virol; 2005 Oct; 79(20):12914-20. PubMed ID: 16188993
[TBL] [Abstract][Full Text] [Related]
3. Evidence that N-linked glycosylation is necessary for hepatitis B virus secretion.
Lu X; Mehta A; Dwek R; Butters T; Block T
Virology; 1995 Nov; 213(2):660-5. PubMed ID: 7491790
[TBL] [Abstract][Full Text] [Related]
4. Glucosidase inhibition enhances presentation of de-N-glycosylated hepatitis B virus epitopes by major histocompatibility complex class I in vitro and in woodchucks.
Norton PA; Menne S; Sinnathamby G; Betesh L; Cote PJ; Philip R; Mehta AS; Tennant BC; Block TM
Hepatology; 2010 Oct; 52(4):1242-50. PubMed ID: 20658465
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B Virus Middle Protein Enhances IL-6 Production via p38 MAPK/NF-κB Pathways in an ER Stress-Dependent Manner.
Li YX; Ren YL; Fu HJ; Zou L; Yang Y; Chen Z
PLoS One; 2016; 11(7):e0159089. PubMed ID: 27434097
[TBL] [Abstract][Full Text] [Related]
6. Reduced secretion of virions and hepatitis B virus (HBV) surface antigen of a naturally occurring HBV variant correlates with the accumulation of the small S envelope protein in the endoplasmic reticulum and Golgi apparatus.
Chua PK; Wang RY; Lin MH; Masuda T; Suk FM; Shih C
J Virol; 2005 Nov; 79(21):13483-96. PubMed ID: 16227269
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hepatitis B virus-infected cells with alpha-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity.
Lazar C; Durantel D; Macovei A; Zitzmann N; Zoulim F; Dwek RA; Branza-Nichita N
Antiviral Res; 2007 Oct; 76(1):30-7. PubMed ID: 17548120
[TBL] [Abstract][Full Text] [Related]
8. A C-terminal PreS1 sequence is sufficient to retain hepatitis B virus L protein in 293 cells.
Gallina A; Gazina E; Milanesi G
Virology; 1995 Oct; 213(1):57-69. PubMed ID: 7483279
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein H drives hepatitis B surface antigen retention and endoplasmic reticulum stress during hepatitis B virus infection.
Liu Y; Maiers JL; Rui Y; Jiang X; Guleng B; Ren J
Int J Biochem Cell Biol; 2021 Feb; 131():105906. PubMed ID: 33370716
[TBL] [Abstract][Full Text] [Related]
10. A substituted tetrahydro-tetrazolo-pyrimidine is a specific and novel inhibitor of hepatitis B virus surface antigen secretion.
Dougherty AM; Guo H; Westby G; Liu Y; Simsek E; Guo JT; Mehta A; Norton P; Gu B; Block T; Cuconati A
Antimicrob Agents Chemother; 2007 Dec; 51(12):4427-37. PubMed ID: 17875990
[TBL] [Abstract][Full Text] [Related]
11. The hepatitis B virus protein MHBs(t) sensitizes hepatoma cells to TRAIL-induced apoptosis through ERK2.
Liang X; Du J; Liu Y; Cui M; Ma C; Han L; Qu Z; Zhang Z; Sun Z; Zhang L; Chen YH; Sun W
Apoptosis; 2007 Oct; 12(10):1827-36. PubMed ID: 17701086
[TBL] [Abstract][Full Text] [Related]
12. Effect of mutations in the small envelope protein of hepatitis B virus on assembly and secretion of hepatitis delta virus.
Jenna S; Sureau C
Virology; 1998 Nov; 251(1):176-86. PubMed ID: 9813213
[TBL] [Abstract][Full Text] [Related]
13. Biogenesis of the hepatitis B viral middle (M) surface protein in a human hepatoma cell line: demonstration of an alternative secretion pathway.
Sheu SY; Lo SJ
J Gen Virol; 1994 Nov; 75 ( Pt 11)():3031-9. PubMed ID: 7964612
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of host ER glucosidase activity prevents Golgi processing of virion-associated bovine viral diarrhea virus E2 glycoproteins and reduces infectivity of secreted virions.
Jordan R; Nikolaeva OV; Wang L; Conyers B; Mehta A; Dwek RA; Block TM
Virology; 2002 Mar; 295(1):10-9. PubMed ID: 12033761
[TBL] [Abstract][Full Text] [Related]
15. alpha-Glucosidase inhibitors have a prolonged antiviral effect against hepatitis B virus through the sustained inhibition of the large and middle envelope glycoproteins.
Simsek E; Lu X; Ouzounov S; Block TM; Mehta AS
Antivir Chem Chemother; 2006; 17(5):259-67. PubMed ID: 17176630
[TBL] [Abstract][Full Text] [Related]
16. Cytokine and hepatitis B virus DNA co-immunizations enhance cellular and humoral immune responses to the middle but not to the large hepatitis B virus surface antigen in mice.
Geissler M; Schirmbeck R; Reimann J; Blum HE; Wands JR
Hepatology; 1998 Jul; 28(1):202-10. PubMed ID: 9657113
[TBL] [Abstract][Full Text] [Related]
17. N-Linked Glycosylation at an Appropriate Position in the Pre-S2 Domain Is Critical for Cellular and Humoral Immunity against Middle HBV Surface Antigen.
Liu H; Wang S; Jia Y; Li J; Huang Z; Lu S; Xing Y
Tohoku J Exp Med; 2015 Jun; 236(2):131-8. PubMed ID: 26062906
[TBL] [Abstract][Full Text] [Related]
18. Posttranslational N-glycosylation of the hepatitis B virus large envelope protein.
Lambert C; Prange R
Virol J; 2007 May; 4():45. PubMed ID: 17537250
[TBL] [Abstract][Full Text] [Related]
19. [Screening proteins in hepatocytes interacting with the middle surface protein of hepatitis B virus using the yeast-two hybrid technique].
Li ZQ; Ma YJ; Cheng J
Zhonghua Gan Zang Bing Za Zhi; 2007 Feb; 15(2):111-3. PubMed ID: 17362635
[TBL] [Abstract][Full Text] [Related]
20. Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels.
Pollicino T; Amaddeo G; Restuccia A; Raffa G; Alibrandi A; Cutroneo G; Favaloro A; Maimone S; Squadrito G; Raimondo G
Hepatology; 2012 Aug; 56(2):434-43. PubMed ID: 22271491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
